|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 血管内超声去肾交感神经术治疗高血压:一项多中心,国际,单盲,随机,假手术对照试验显示文摘早期研究表明,基于射频的去肾交感神经术可降低中度高血压患者的血压。研究者研究了在没有使用抗高血压药物的情况下,使用血管内超声去。肾交感神经术是否会降低高血压患者的动态血压。 | 刘青 叶鹏 Azizi M Schmieder RE Mahfoud F Weber MA Daemen J Davies J Basile J Kirtane AJ Wang Y Lobo MD Saxena M Feyz L Rader F Lurz P Sayer J Sapoval M Levy T Sanghvi K Abraham J Sharp ASP Fisher NDL Bloch MJ Reeve-Stoffer H Coleman L Mullin C Mauri L | 2018 | 中华高血压杂志2018，26，10： | 27 |
| 2 | Effect of B vitamin supplementation on plasma homocysteine levels in celiac disease显示文摘AIM: To investigate the effect of vitamin supplements on homocysteine levels in patients with celiac disease. METHODS: Vitamin B6, folate, vitamin B12, and fasting plasma homocysteine levels were measured in 51 consecutive adults with celiac disease [median (range) age 56 (18-63) years; 40% men, 26 (51%) had villous atrophy, and 25 (49%) used B-vitamin supplements] and 50 healthy control individuals matched for age and sex. Finally, the C677T polymorphism of 5,10-methylene tetrahydrofolate reductase (MTHFR) was evaluated in 46 patients with celiac disease and all control individuals. RESULTS: Patients with celiac disease and using vitamin supplements had higher serum vitamin B6 (P = 0.003),folate (P < 0.001), and vitamin B12 (P = 0.012) levels than patients who did not or healthy controls (P = 0.035, P < 0.001, P = 0.007, for vitamin B6, folate, and vitamin B12, respectively). Lower plasma homocysteine levels were found in patients using vitamin supplements than in patients who did not (P = 0.001) or healthy controls (P = 0.003). However, vitamin B6 and folate, not vitamin B12, were significantly and independently associated with homocysteine levels. Twenty-four (48%) of 50 controls and 23 (50%) of 46 patients with celiac disease carried the MTHFR thermolabile variant T-allele (P = 0.89). CONCLUSION: Homocysteine levels are dependent on Marsh classification and the regular use of B-vitamin supplements is effective in reduction of homocysteine levels in patients with celiac disease and should be considered in disease management. | Muhammed Hadithi Chris JJ Mulder Frank Stam Joshan Azizi J Bart A Crusius Amado Salvador Pea Coen DA Stehouwer Yvo M Smulders | 2009 | World Journal of Gastroenterology2009，15，8： | 3 |
| 3 | Genetic diversity of HCV among various high risk populations(IDAs,thalassemia,hemophilia,HD patients) in Iran显示文摘Objective:To determine the patterns of distribution of HCV genotypes among high risk population in north of Iran.Methods:A cross-sectional study was conducted on 135 HCV RNA-positive high risk individuals including thalassemia,hemophilia,patients under hemodialysis and intravenous drug addicts.HCV genotypes were determined based on amplification with type-specific primers methods.Results:Among the 187 anti-HCV positive samples,only 135 (72.2%)gave HCV-RNA positvity.Over all,the most identified HCV type was genotype 3a(51.1%) followed by 1a(27.4%),1b(8.2%).Sixteen(11.9%)out of 135 HCV RNA-positive participants have infected with more than one genotype or subtypes as follow:1a/1b in 11(8.2%),2/3a in 3 (2.2%),and 1a/1b/3a in 2(1.5%).Stratification of participants revealed that HCV subtype 3a was more prominent in thalassemia,hemophilia and HD patients but 1a and 1b were frequent in intravenous drug addicts.Conclusions:This study is the first report on HCV genotypes among Iranian subjects with different exposure categories resided in Mazandaran.where genotype 3a was found to be the most frequent genotype in thalassemia,hemophilia,and hemodialysis patients but not in IDAs.Since the addiction age is decreasing in Iran and a lot of addicts are IDAs.it might change the subtype pattern of HCV in general population. | Rafiei A Darzyani Azizi M Taheri S Haghshenas MR Hosseinian A Makhlough A | 2013 | Asian Pacific Journal of Tropical Medicine2013，6，7： | 2 |
| 4 | Association of lipids, lipoproteins, apo-lipoproteins and paraoxonase enzyme activity with premature coronary artery disease显示文摘 | Azizi F Rahmani M Raiszadeh F | 2002 | Coron Artery Dis2002，13，1： | 1 |
| 5 | Determination of fatty acids and total lipid content in oil seed of 25 pomegranates varieties grown in Iran显示文摘 | Fadavi A Barzegar M Azizi H M | 1998 | J Food Comp Anal1998，，19： | 1 |
| 6 | Management of resistant hypertension显示文摘 | Briet M Bobrie G Azizi M | 2013 | Rev Prat2013，63，5： | 1 |
| 7 | Performanee of elastography for the evaluation of thyroid nodules:a prospective study显示文摘 | Azizi G Keller J Lewis M | 2013 | Thyroid2013，23，6： | 1 |
| 8 | Alisldren,an orally effective rennin inhibitor,provides antihypertensive efficacy alone and in combination with vaLsartan显示文摘 | Pool J Schmieder R Azizi M | 2007 | American Journal of Hypertemion2007，20，1： | 1 |
| 9 | Blocking the tissue rennin - angiotension system:the future cornerstone of therapy显示文摘 | Unger T Azizi M Belz GG | 2000 | J Hum Hypertens2000，14，2： | 1 |
| 10 | Phytochemical composition of the essential oils from three Apiaceae species and their antibacterial effects on food-borne pathogens显示文摘 | Oroojalian F Kasra-Kermanshahi R Azizi M | 2010 | Food Chemistry2010，120，： | 1 |
| 11 | 查看详情显示文摘 | Yazdani H Ghasemi I Karrabi M Azizi H Bakhshandeh G R | | 0，，1： | 1 |
| 12 | Angiotensin I-converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline 显示文摘 | Azizi M Junot C Ezan E | 2001 | Clin Exp Pharmacol Physiol2001，28，12： | 1 |
| 13 | Pilot study of combined blockade of the renin-angiotensin system in essential hypertensive patients显示文摘 | Azizi M Linhart A Alexander J | 2000 | J Hypertens2000，18，： | 1 |
| 14 | Expert consensus: renal denervation for the treatment of hypertension 显示文摘 | Pathak A Girerd X Azizi M | 2012 | Diagn Interv Imaging2012，93，5： | 1 |
| 15 | Long-term hemodynamic benefit of biventficular pacing depending on coronary sinus lead position 显示文摘 | Nagele H Hashagen S Azizi M | 2006 | Herzschrittmacherther Elektrophysiol2006，17，4： | 1 |
| 16 | LiClO4 accelerated Michael addition of amines to a, b-unsaturated olefins under solvent-free conditions显示文摘 | Azizi N Saidi M R | 2004 | Tetrahedron2004，60，： | 1 |
| 17 | Additive effects of combined angiotensin- converting enzyme inhibition and angiotensin-Ⅱantagonism on blood pressure and rennin release I sodium depleted normotensives显示文摘 | Azizi M Chatellier G Guyene T | 1995 | Circulation1995，92，9： | 1 |
| 18 | Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin Ⅱ-renin feedback interruption显示文摘 | AZIZI M MENARD J BISSERY A | 2004 | J Am Soc Nephrol2004，15，12： | 1 |
| 19 | Normal and pathologic features of the postoperative biliary tract at 3D MR cholangiopancreatography and MR Imaging 显示文摘 | Hoeffel C Azizi L Lewin M | 2006 | Radiographies2006，26，6： | 1 |
| 20 | Additive Efects of Combined Angiotensin Converting Enzyme Inhibition and Angiotensin Ⅱ Antagoism on Blood Pressure and Rennin Release I Sodium-depleted Normotensives显示文摘 | Azizi M Chauellier G Guyene T | 1995 | Circulation1995，9，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员